Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)

Funding Opportunity RFA-FD-19-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity is to solicit applications to conduct studies that could support the approval of label changes to establish more targeted durations of use for certain approved medically important antimicrobial new animal drugs in food animals. These cooperative agreements are intended to provide publicly available data to be used by sponsor(s) of affected approved new animal drugs to support approval of future supplemental new animal drug applications. Such supplemental new animal drug applications are intended to: 1) Revise approved dosage regimens to provide for use durations that are more targeted (i.e., are more specifically defined) and, 2) That the revised dosage regimens continue to provide effectiveness that is comparable to the currently approved regimen while reducing the risk of antimicrobial resistance development.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding